Product Recalls in North Dakota

Product recalls affecting North Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to North Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,526 recalls have been distributed to North Dakota in the last 12 months.

47,938 total recalls
2,526 in last 12 months

Showing 1156111580 of 13,369 recalls

DrugMarch 3, 2014· Novartis Pharmaceuticals Corp.

Recalled Item: Ritalin HCl (methylphenidate HCl) USP Recalled by Novartis Pharmaceuticals...

The Issue: Labeling: Incorrect or Missing Package Insert; The back of the Medication...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 3, 2014· Terra-Medica Inc.

Recalled Item: Pleo Quent SUPPOSITORIES 3X Recalled by Terra-Medica Inc. Due to Penicillin...

The Issue: Penicillin Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 3, 2014· Terra-Medica Inc.

Recalled Item: Pleo Not TABLETS 5X Recalled by Terra-Medica Inc. Due to Penicillin Cross...

The Issue: Penicillin Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2014· Pfizer Us Pharmaceutical Group

Recalled Item: Advil PM Caplets Recalled by Pfizer Us Pharmaceutical Group Due to Subpotent...

The Issue: Subpotent Drug: This lot is being recalled because of out-of-specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette Lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette (nicotine polacrilex) Lozenges Mini Recalled by GlaxoSmithKline...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette (nicotine polacrilex) Lozenges Mini Recalled by GlaxoSmithKline...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette Lozenge and NicoDerm CQ Recalled by GlaxoSmithKline Consumer...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2014· Gilead Sciences, Inc.

Recalled Item: Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil...

The Issue: Presence of Foreign Substance: Red Silicone Rubber Particulates are Present...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 14, 2014· Ben Venue Laboratories Inc

Recalled Item: Acetylcysteine Solution Recalled by Ben Venue Laboratories Inc Due to...

The Issue: Presence of Particulate Matter: During a review of retain samples, the firm...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 14, 2014· Medisca Inc

Recalled Item: CITRULLINE (L) in 25 g Recalled by Medisca Inc Due to Labeling: Label...

The Issue: Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 14, 2014· Legacy Pharmaceutical Packaging

Recalled Item: Fluoxetine Capsules Recalled by Legacy Pharmaceutical Packaging Due to...

The Issue: Chemical Contamination: The recalling firm received notice that their...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 14, 2014· Agila Specialties Private Ltd.

Recalled Item: etomidate injection Recalled by Agila Specialties Private Ltd. Due to...

The Issue: Presence of Particulate Matter: Potential for small black particles to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 13, 2014· Noven Pharmaceuticals, Inc.

Recalled Item: Daytrana (methylphenidate) transdermal system patch Recalled by Noven...

The Issue: Defective Delivery System: Out of Specification (OOS) results for the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund